Evidence map›Paper›PMID 37584811›Full record

ArticleJournal of medical systems2023

AI-Based Optimal Treatment Strategy Selection for Female Infertility for First and Subsequent IVF-ET Cycles.

Renjie Wang, Wei Pan, Lean Yu, Xiaoming Zhang, Wulin Pan, Cheng Hu, Li Wen, Lei Jin, Shujie Liao

Abstract read
PubMed Publisher
In one paragraph

Article in Journal of medical systems, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.8field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 3 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 5 institutions in 1 country.

Renjie WangDepartment of Obstetrics and Gynecology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, 430030, PR China.
Wei PanSchool of Applied Economics, Renmin University of China, Beijing, 100872, China. mrpanwei2000@163.com.
Lean YuBusiness School, Sichuan University, Chengdu, 610064, China. yulean@amss.ac.cn.
Xiaoming ZhangSchool of Information Management, Jiangxi University of Finance and Economics, Nanchang, 330032, China. zhxmdy@163.com.
Wulin PanSchool of Economic and Management, Wuhan University, Wuhan, 430072, China.
Cheng HuSchool of Economic and Management, Wuhan University, Wuhan, 430072, China. 995409373@qq.com.
Li WenSchool of Applied Economics, Renmin University of China, Beijing, 100872, China.
Lei JinDepartment of Obstetrics and Gynecology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, 430030, PR China. 57657713@qq.com.
Shujie LiaoDepartment of Obstetrics and Gynecology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, 430030, PR China. sjliao@tjh.tjmu.edu.cn.
Huazhong University of Science and Technology · CNRenmin University of China · CNWuhan University · CNChengdu University · CNJiangxi University of Finance and Economics · CN

Funding

National Natural Science Foundation of China 71871169;U1933120the Chinese Medical Association of Clinical Medicine special funds for scientific research projects 17020400709the Hubei Provincial Natural Science Foundation of China 2019CFA062
6 · The paper itself

Abstract

Over the last 20 years, China's infertility rate has risen from 3% to 12.5%-15%. Infertility has become the third largest disease following cancer and cardiovascular disease. Then, the in vitro fertilization and embryo transfer (IVF-ET) becomes more and more important in infertility treatment field. However, the reported success rate for IVT-ET is 30%-40% and costs are gradually rising. Meanwhile, to increase success rates and decrease costs, the optimal selection of the IVF-ET treatment strategy is crucial. In a clinical work, the IVF-ET treatment strategy selection is always based on the experience of the doctor without a uniform standard. To solve this important and complex problem, we proposed an artificial intelligence (AI)-based optimal treatment strategy selection system to extract implicit knowledge from clinical data for new and returning patients, by mimicking the IVF-ET process and analysing a myriad of treatment decisions. We demonstrated that the performance of the model was different in 10 AI classification algorithms. Hence, we need to select the optimal method for predicting patient pregnancy result in different IVF-ET treatment strategies. Moreover, feature ranking is determined in the proposed model to measure the importance of each patient characteristics. Therefore, better advice can be provided for individual patient characteristics, doctors can provide more valid suggestions regarding certain patient characteristics to improve the accuracy of diagnosis and efficiency.

Indexed as

Infertility, FemaleArtificial IntelligenceCosts and Cost AnalysisEmbryo TransferFemaleFertilization in VitroHumansPregnancyAI classification algorithmFeature rankingInfertilityIVF-ETTreatment strategy selection

Identifiers

PMID37584811
OpenAlexW4385851199

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.